Your browser doesn't support javascript.
loading
Safety and effectiveness of dulaglutide in Chinese adults with type 2 diabetes mellitus in a real-world setting: A prospective, observational post-marketing study.
Guo, Lixin; Li, Li; Yu, Qiurong; Wang, Na; Chen, Jun; Xi, Yue; Wang, Huan; Wang, Yihua; Xu, Jiawei.
Affiliation
  • Guo L; Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Science, Beijing, China.
  • Li L; Department of Endocrinology, Ningbo First Hospital, Zhejiang, China.
  • Yu Q; Department of Endocrinology, Changshu Second People's Hospital, Suzhou, China.
  • Wang N; Department of Endocrinology, Qingdao Endocrine and Diabetes Hospital, Qingdao, China.
  • Chen J; Department of Endocrinology, Xiaoshan Affiliate Hospital of Wenzhou Medical University, Hangzhou, China.
  • Xi Y; Department of Endocrinology, The Third Affiliated Hospital of Jinzhou Medical University, Liaoning, China.
  • Wang H; Eli Lilly Suzhou Pharmaceutical Co. Ltd, Shanghai, China.
  • Wang Y; Eli Lilly Suzhou Pharmaceutical Co. Ltd, Shanghai, China.
  • Xu J; Eli Lilly Suzhou Pharmaceutical Co. Ltd, Shanghai, China.
Diabetes Obes Metab ; 25(12): 3578-3588, 2023 12.
Article in En | MEDLINE | ID: mdl-37612876

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetes Mellitus, Type 2 Type of study: Risk_factors_studies Limits: Adult / Humans Language: En Journal: Diabetes Obes Metab Journal subject: ENDOCRINOLOGIA / METABOLISMO Year: 2023 Document type: Article Affiliation country: China

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetes Mellitus, Type 2 Type of study: Risk_factors_studies Limits: Adult / Humans Language: En Journal: Diabetes Obes Metab Journal subject: ENDOCRINOLOGIA / METABOLISMO Year: 2023 Document type: Article Affiliation country: China